Hey Bottle,
Not quite correct. The comparable quarter (to current) had revenue of $6.1M. This has nothing to do with the R&D rebate. The rebate boosts cash received in the quarter and minimises cash outflows, but is not part of the revenue figure. I have this quarter at a 30% increase on the previous, which is only a 9% increase on PCP. ( I think and hope that this may prove to be a conservative estimate).
My thoughts on AHZ, page-174
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.97 |
Change
-0.380(2.07%) |
Mkt cap ! $348.5M | |||
| Open | High | Low | Value | Volume |
| $18.36 | $18.47 | $17.55 | $105.6K | 5.898K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 426 | $17.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.96 | 26 | 3 |
View Market Depth
| Last trade - 11.57am 03/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |